Sebastian A. Brunemeier

About

Building and investing in longevity biotech ("LongBio") companies that address the molecular mechanisms of aging ("geroscience"). - GP @ Healthspan Capital - Co-founder & CIO of Cambrian Bio - Principal at Apollo Health Ventures - Founder & COO of Samsara Therapeutics - CEO @ ImmuneAGE Bio, Cyclone Tx - Oxford Biochemistry PhD (DPhil) dropout (to co-found Cambrian) and Clarendon Scholar - MSc in Molecular Neuro & Biotech Business Management @ Uni Amsterdam - Advisor to Longevity Biotech Fellowship, LongGame Ventures, and more Bio: Sebastian A. Brunemeier is a biotech VC and company builder focused on longevity & regenerative medicine. He is Co-Founder and General Partner of Healthspan Capital, and CEO and Founder of ImmuneAGE Bio (stealth), focused on immune system rejuvenation. Over the last 5 years, he has co-founded 4 longevity biotech (“LongBio”) companies with a total equity value of >$600M. He was Co-Founder and Chief Investment Officer at Cambrian Biopharma, Founder and COO of Samsara Therapeutics, and Principal at Apollo Health Ventures (the first and largest aging-focused venture capital fund in the world with $200M AUM). Altogether, these organizations have raised ±$400M

Experience

Education